In a patient undergoing chemotherapy, why does aplastic anemia frequently manifest as thrombocytopenia and neutropenia in addition to erythrocyte deficiency?

💡 Explanation

Aplastic anemia, particularly in chemotherapy patients, often presents as pancytopenia because chemotherapeutic agents damage bone marrow stem cells, which are responsible for producing all blood cell lineages. Therefore, erythrocytes, thrombocytes, and neutrophils are all reduced rather than a single cell type, because of stem cell suppression.

• An individual undergoes chemotherapy, which affects rapidly dividing cells, including those in bone marrow and hair follicles. Which consequence related to cellular aging becomes most prominent following treatment?
• If an elderly patient experiences diminished kidney function, what effect is most likely on bone mineral density due to disrupted mineral homeostasis?
• Why does cellular senescence increase in aging muscle tissue, contributing to sarcopenia?
• If a retinal ganglion cell's receptive field center receives intense light while the surround receives moderate light, which consequence follows?
• A football player sustains a helmet-to-helmet collision; if the resulting rapid head acceleration induces diffuse axonal injury via shear strain, which recovery protocol will be most effective?
• Why does antibiotic resistance in *Pseudomonas aeruginosa* rapidly increase in cystic fibrosis patients undergoing prolonged aerosolized antibiotic therapy?